fragmentation and free-radical-induced lipid peroxidation have In the present study, we found that oxidized low density been implicated as mechanisms of Ox-LDL cytotoxicity lipoprotein, but not low density lipoprotein, down-regulated (18, 19) . Lipid peroxidation is known to induce oxidative DNA base excision repair activity in extracts of mouse monocyte damage (20, 21) . Taken together, these results suggest that cell line PU5-1.8. An enzyme required in this pathway, oxidative DNA damage may be one of the underlying mechan-DNA polymerase β, was also down-regulated. In contrast, isms of vascular cell death caused by Ox-LDL in atherosclerotic treatment of monocytes with a combination of ascorbate lesions. These oxidative DNA lesions are efficiently and and α-tocopherol up-regulated base excision repair activity quantitatively repaired primarily by the base excision repair and expression of DNA polymerase β. Co-treatment of (BER) pathway, which is generally considered to be a constitumonocytes with antioxidants plus oxidized low density tively expressed repair system in mammalian cells (7, (22) (23) (24) (25) . lipoprotein prevented down-regulation by oxidized low Therefore, enzymes involved in the BER pathway play a key density lipoprotein. Oxidative DNA damage, as measured role in allowing the cell to respond to oxidative DNA damage. by 8-hydroxyguanine accumulation in genomic DNA, was
If oxidative DNA damage is left unrepaired, deleterious found in cells treated with oxidized low density lipoprotein; consequences ensue, including mutation, DNA fragmentation,
8-hydroxyguanine was not found in the cells treated with
altered gene expression and cell death. low density lipoprotein, antioxidants or oxidized low density Antioxidants have been widely used for the prevention of lipoprotein plus antioxidants. These results establish a atherosclerosis due to their function as free radical scavengers linkage between the DNA base excision repair pathway, that decrease the initiation and propagation of fatty acid oxidative DNA damage and oxidized low density lipoprotein oxidation. Strong epidemiological evidence links dietary antitreatment in mouse monocytes. Since oxidized low density oxidants to a decrease in LDL oxidation and to the reduced lipoprotein is implicated in chronic disease conditions such clinical expression of atherosclerosis; use of the antioxidants, as atherogenesis, these findings facilitate understanding of such as ascorbate, α-tocopherol and probucol, in animal model genetic toxicology mechanisms related to human health studies have shown that the anti-oxidation mechanism accounts and disease.
for the inhibitory effect of these agents on atherogenesis (26-29). The antioxidant protective mechanism against oxidative damage is accomplished by quenching free radicals or reacting Introduction with their products (30,31). Therefore, antioxidants can decrease the amount of oxidative damage to DNA, proteins and Coronary artery disease is the major cause of morbidity and other macromolecules. Although observational epidemiological mortality in the United States and most Western countries. studies have produced some intriguing results, they have not Even though the precise molecular mechanism and sequence unequivocally established that a high intake of antioxidants of events involved in the initiation and progression of this disease remain to be elucidated, there is a wealth of evidence leads to decreased risk of cardiovascular disease (32-34). Thus, demonstrating that atherosclerotic lesions result from an intensive study of the molecular mechanisms of prevention of excessive inflammatory response mediated by reactive oxygen atherosclerotic lesion formation by antioxidants is warranted. species (ROS) (1) (2) (3) (4) (5) , which are known to have deleterious In addition, the response to oxidative stress is considered to effects on cells, including causing lipid peroxidation and be linked to carcinogenesis, and therefore this area of research oxidative DNA damage (6) (7) (8) .
has relevance to cancer biology as well. 
Materials and methods

Analysis of 8-hydroxyguanine Materials
HPLC analysis of 8-oxo-G was performed according to the methods described previously (42). Monocytes were incubated in 1.2 ml digestion buffer (10 Low density lipoprotein, cupric sulfate, Chelex-100, creatine phosphokinase, mM Tris-HCl, pH 8.0, 100 mM NaCl, 25 mM EDTA, 5% SDS, 0.1 mg/ml diTris-phosphocreatine, nicotinamide adenine dinucleotide, proteinase K, proteinase k and 10 µg/ml RNase) at 37°C for 18 h. After digestion, NaCl ribonuclease, DNA polymerase I, DNase I and alkaline phosphatase were was added to a final concentration of 1 M followed by centrifugation at obtained from Sigma (St Louis, MO). Dulbecco's modified Eagle medium 4000 r.p.m. for 15 min. The supernatant fraction was extracted twice with (DMEM), F-10 nutrient mixture (Ham), heat-inactivated fetal bovine serum chloroform:isoamyl alcohol (24:1) and DNA was precipitated by the addition and gentamycin were purchased from Gibco BRL-Life Technologies (Gaithersof one-half volume of 7.5 M ammonium acetate and two volumes of ethanol. burg, MD). Fetal bovine serum was obtained from Hyclone Laboratories
The mixture was kept at -20°C for 2 h and centrifuged. DNA was resuspended (Logan, UT). dNTPs were obtained from Pharmacia LKB Biotechnology in 10 mM Tris-HCl pH 7.4 and the quantity and purity was determined. (Piscataway, NJ). [α-32 P]dCTP was from DuPont NEN (Boston, MA). 8-oxoSamples were digested with DNase I (40 U/100 µg DNA) in the presence of G and dG were obtained from Wako Pure Chemical Industry (Houston, TX).
10 mM MgSO 4 at 37°C for 30 min. The P1 nuclease digestion was carried Oligonucleotides were purchased from Operon Technologies (Alameda, CA).
out in the same buffer at 37°C for 2 h with the addition of 0.5 M sodium Mouse monocyte cell line (PU5-1.8) was obtained from American Type acetate (pH 7.0) to lower the pH to 7.0 and 1 M ZnSO 4 to a final concentration Culture Collection (Rockville, MD). of 1 mM. Alkaline phosphatase (2.5 U/100 µg DNA) was added to the mixture Cell culture and incubated for an additional 30 min. Acetone (5 ml, HPLC grade) was added to the mixture to precipitate enzymes. Solvent was evaporated under To determine the effect of LDL, Ox-LDL, ascorbate and α-tocopherol on β-nitrogen gas at temperatures not exceeding 30°C. The residues were dissolved pol expression, BER activity and DNA lesion formation, a mouse monocyte in a small volume of mobile phase solution (100 mM sodium acetate, pH 5.2, cell line (PU5-1.8) was grown in a humidified atmosphere with 10% CO 2 in 5% methanol) and filtered through a 0.2 µm membrane prior to HPLC analysis DMEM containing gentamycin (50 µg/ml), L-glutamine (4 mM) and heatusing a model 580 dual piston pump and a model 5200A coulochem II inactivated fetal bovine serum (10%) at 37°C. For experiments, cells were electrochemical detector (ESA, Bedford, MA). The potentials were set at split by manual disruption, centrifuged, resuspended in F-10 nutrient mixture ϩ850 mV for the guard cell, ϩ100 mV for the conditioning cell, and ϩ500 (Ham), plated at a concentration of 4ϫ10 6 cells/100 mm dish and grown and ϩ800 mV for electrodes 1 and 2, respectively for the analytical cell. 8-overnight. At the initiation of the experiment, cells were replenished with oxo-G and dG were separated on a YMCB-02-3 C8 base-deactivated 3µ, 4.6 fresh F-10 nutrient mixture and treated with LDL, Ox-LDL, ascorbate and α-mmϫ15 cm column (YMC, Wilmington, NC) under isocratic conditions by tocopherol alone or a combination of these agents as described in the text. a mobile phase containing 100 mM sodium acetate, pH 5.2 (adjusted with Control cells were treated with medium only. The data are from three HPLC grade phosphoric acid) at a flow rate of 1 ml/min. The chromatograms independent experiments with a single result of a typical experiment shown.
were collected and analyzed by chromjet dual channel integrator (Spectra For testing the effect of LDL, Ox-LDL, ascorbate and α-tocopherol on the physics, Fremont, CA). Concentrations of 8-oxo-G, obtained from channel 1 level of 8-oxo-G in mouse monocyte genomic DNA, cells were treated with that linked to electrode 1 at a potential of ϩ500 mV, were expressed relative the reagents at the following concentrations: LDL, 0.5 µg; Ox-LDL, 0.5 µg;
to the concentrations of dG, obtained from channel 2 that linked to electrode ascorbate, 40 µM; α-tocopherol, 2 µM. Cells were incubated for 4 or 8 h 2 at a potential of ϩ800 mV. prior to isolation of genomic DNA samples and 8-oxo-G determination was carried out as described below.
Results
Preparation of oxidized low density lipoprotein
Effects of antioxidants on β-pol level antioxidants on β-pol expression was determined in mouse Western blotting analysis monocytes. Cells were treated with either ascorbate (40 µM) The β-pol protein level was determined by western blotting as described or α-tocopherol (2 µM). β-Pol was induced about 2-fold previously (38,40). Briefly, after treatment, control and treated cell-free extracts throughout the 8 h period of treatment with either ascorbate were prepared as follows. Cells were scraped and centrifuged at 500 g for 5 min at 4°C, washed once with ice-cold PBS, lysed in RIPA buffer (10 mM or α-tocopherol (Figure 1) . In contrast, when cells were Tris-HCl, pH 7.5, 150 mM NaCl, 0.5% sodium deoxycholate, 1% Triton exposed to a combination of ascorbate (40 µM) and α-X-100, 0.1% SDS, 1 mM EDTA, 1 mM dithiothreitol, 1 mM PMSF and 2.7 tocopherol (2 µM), β-pol protein level increased 3.5-fold after µg/ml aprotinin), and the lysates were microcentrifuged at 11 000 r.p.m. for 1 h and the highest level of induction was 5.5-fold at 4 h. To test the effect of Ox-LDL on the β-pol protein level in with mouse monoclonal 18 S antibody to β-pol followed by antibody to mouse immunoglobulin G (IgG) conjugated to horseradish peroxidase (HRP) mouse monocytes, cells were exposed to 0.5 µg/ml Ox-LDL. Fig. 1 . Effect of ascorbate, α-tocopherol or ascorbate plus α-tocopherol on the β-pol level in mouse monocytes. Results are expressed as fold-increase over control in β-pol protein level as measured by quantitative immunoblotting. Cells were treated with ascorbate (40 µM) (s) or α-tocopherol (2 µM) (n) or ascorbate (40 µM) plus α-tocopherol (2 µM) (j) and harvested at the indicated time. β-Pol level was determined using the crude cell extract as described under Materials and methods. antioxidants, and then the β-pol level was analyzed. The results indicated that co-treatment with ascorbate and α-tocopherol prevented the down-regulation of β-pol by Ox-LDL and resulted in a modest increase in β-pol level as compared with the control (Figure 2) .
Effect of ascorbate, α-tocopherol, LDL and Ox-LDL on BER
Previous studies demonstrated that β-pol carries out short patch gap-filling DNA synthesis in an in vitro BER assay with an oligonucleotide substrate (41). Since ascorbate plus α-tocopherol and Ox-LDL differentially modulate expression of β-pol in monocytes, we treated monocytes with the antioxidants in vitro (41). BER activity was determined from the amounts of both the fully repaired 51 base pair molecule containing Ox-LDL at this concentration did not have an effect on cell dCMP instead of dUMP and the unligated single nucleotide viability as measured by trypan blue exclusion (data not replacement intermediate (i.e. 22 nucleotide molecule with shown). The results indicated that the β-pol level was reduced dCMP at position 22). With the untreated cell extract, most of after 1 h exposure to Ox-LDL ( Figure 2) ; β-pol level decreased the BER product corresponded with the 22 nucleotide-long to~50 and~20% of the control level (without treatment) after unligated molecule, indicating that the mouse monocyte cell exposure to Ox-LDL for 4 and 8 h, respectively. extract was relatively deficient in DNA ligase activity compared To determine whether the down-regulation of β-pol is with bovine testis nuclear extract (41) or mouse fibroblast specific for Ox-LDL, the effect of non-oxidized LDL on the extract (43). The data show that ascorbate plus α-tocopherol β-pol level was determined. Cells were exposed to 0.5 µg/ml up-regulated BER (Figure 3 ). This was especially evident from LDL and the β-pol level was analyzed. LDL had no effect on the amount of 51 nucleotide product formed. In contrast, Oxthe β-pol protein level during 8 h of treatment (data not shown).
LDL down-regulated BER (Figure 4) . Further, co-treatment Since antioxidants both up-regulate β-pol level in monocytes with ascorbate plus α-tocopherol prevented the down-regulaand potentially inactivate ROS, we studied whether treatment tion of BER by Ox-LDL (Figure 4) . In contrast, non-oxidized of antioxidants would influence the β-pol down-regulation by Ox-LDL. Monocytes were co-treated with Ox-LDL and both LDL did not affect BER activity (data not shown).
macrophage cell death in atherosclerotic lesions in the arterial wall (47). The results presented in this paper demonstrate that Ox-LDL, but not LDL, down-regulates DNA BER activity in extracts of mouse monocytes and results in accumulation of oxidative DNA damage in genomic DNA. Co-treatment with antioxidants plus Ox-LDL prevents these effects, suggesting that an oxidative mechanism is involved in the Ox-LDL effect. Since unrepaired oxidative DNA damage may be harmful to cells, our findings provide useful insight into the potential mechanism of atherosclerotic plaque formation. Penn et al.
(35-37) have proposed that somatic cell mutations are involved in the etiology of atherosclerosis and in macrophage death (apoptosis) in advancing atherosclerotic plaques.
In these experiments, cells were treated with a low concentration (0.5 µg/ml) of Ox-LDL, that is more likely to be physiologically relevant than the high concentration (100 µg/ ml) used by Reid et al. (47) . Oxidative DNA damage was detected after 8 h of exposure to Ox-LDL; however, no 8-oxo-G was found after 4 h exposure. The DNA damage and the increased level of 8-oxo-G/dG are in agreement with earlier reports (48) (49) (50) . These results suggest that either the cellular DNA repair capacity is sufficient to repair the DNA damage after a 4 h exposure, or that the time required for Ox-LDL to repair of oxidative DNA damage (7, (22) (23) (24) (25) . It would be interesting to determine whether Ox-LDL treatment would result in accumulation of a higher level of oxidative DNA Effect of LDL and Ox-LDL on DNA damage damage and occur earlier in monocytes with a β-pol gene deletion created by a tissue specific knock-out procedure (51). To determine whether there is a correlation between the level The oxidative hypothesis of atherosclerosis presumes that of oxidative genomic DNA damage and the down-regulation compounds which limit vascular oxidative stress should also of BER activity, monocytes were treated with LDL and Oxlimit atherogenesis and atherosclerosis. It has been shown that LDL and analyzed for oxidative DNA damage by measuring ascorbate and α-tocopherol act synergistically to reduce free the 8-oxo-G level. 8-oxo-G level (2.3ϫ10 -5 ) was significantly radicals through a mechanism by which ascorbate regenerates higher in monocytes exposed to Ox-LDL for 8 h than in α-tocopherol, which in turn acts as the primary antioxidant untreated control cells or in cells treated with Ox-LDL for 4 (30). Therefore, both antioxidants have been widely used in h (1-3ϫ10 -6 ). Since antioxidants prevented down-regulation animal models and human studies in an attempt to prevent of β-pol and BER by Ox-LDL (Figures 2 and 4) , we examined atherosclerosis (26-29). We examined the question of whether the effect of antioxidants on the level of oxidative DNA both antioxidants could prevent the down-regulation of β-pol damage in the cells. We found that ascorbate plus α-tocopherol level and BER activity in monocytes treated with Ox-LDL. In prevented the Ox-LDL-induced accumulation of 8-oxo-G (8 h contrast to the down-regulation of β-pol and BER observed in exposure) and that the antioxidants alone (4 or 8 h exposure) the presence of Ox-LDL, ascorbate plus α-tocopherol protects had no effect on the level of oxidative DNA damage as against this down-regulation of β-pol ( Figure 2 ) and BER compared with the control.
( Figure 4) . The mechanism by which antioxidants prevent the down-regulation of β-pol and BER by Ox-LDL could be the Discussion reduction of Ox-LDL to LDL by the antioxidants before cellular uptake. It is also possible that ascorbate and α-It is increasingly evident that Ox-LDL contributes to the development of atherosclerosis. Ox-LDL is toxic in vitro tocopherol could function in intracellular compartments to reduce Ox-LDL to LDL. Our results suggest that the latter to all cell types found in atherosclerotic lesions, including endothelial cells, smooth muscle cells and macrophages mechanism is most practical since a combination of both antioxidants not only prevented the down-regulation of β-pol (16, 17) . The mechanism of toxicity is not known; however, it has been suggested that Ox-LDL generates ROS (44-46). It and BER by Ox-LDL, but also up-regulated β-pol and BER (Figures 1-4) . is known that ROS cause oxidative DNA damage in cells. A previous study by Reid et al. (47) showed that a murine In summary, these results demonstrate a linkage between Ox-LDL exposure, reduced DNA repair capacity and increased macrophage cell line exposed to a high concentration (100 µg/ ml) of Ox-LDL for 24 h demonstrated DNA fragmentation oxidative DNA damage in monocytes. Understanding the function of DNA repair in monocytes exposed to Ox-LDL and apoptosis. These results suggest that Ox-LDL may cause DNA damage and that apoptosis might be a mechanism of may provide new insights into oxidant-induced atherosclerosis.
